Democrats such as Elizabeth Warren had their eye on business and the working class during the first 2020 presidential primary debate in Miami.2020 Electionsread more
The issue over health insurance marked the first stark divide among the candidates, and sparked a heated back-and-forth between many of the candidates on stage.Politicsread more
Huawei's legal chief told CNBC that the company makes "solutions for civil use."Technologyread more
Four candidates mentioned China — but none of the Democratic contenders brought up trade in the debate.Politicsread more
In a strategy to draw attention away from Wednesday's Democratic debate, President Donald Trump's reelection campaign bought out YouTube's "masthead," the leading...2020 Electionsread more
The Federal Aviation Administration said on Wednesday that is has found an issue with the Boeing 737 Max that the manufacturer must address before it lifts the grounding...Airlinesread more
The collapse of the deal potentially ended Sinclair's hopes of building a national conservative-leaning TV powerhouse that might have rivaled Fox News.Mediaread more
Huawei legal chief Song Liuping told CNBC that the company is in the "early phase" of talks with Verizon over paying royalties.Technologyread more
Virginia Sen. Mark Warner breaks down the idea behind a bipartisan bill he introduced to provide more transparency in Big Tech.Technologyread more
U.S. President Donald Trump on Thursday asked India to withdraw retaliatory tariffs that New Delhi imposed this month, calling the duties "unacceptable."World Economyread more
Wi-Fi 6 will be the next-generation wireless standard. Along with 5G, it will represent the next big shift in connectivity and data, said Irving Tan, senior vice president and...Shaping the futureread more
The Cleveland Clinic's CEO said Friday that the top-rated U.S. hospital will work to verify technology developed by blood-testing start-up Theranos, which has recently faced allegations its devices are inaccurate.
"Everybody is skeptical about something that is disruptive in a new industry, and I think that's perfectly reasonable that they should be," Dr. Toby Cosgrove told CNBC's "Squawk Box." "I think that we need to have that verification done externally by a third party and we'd like to do that.
In March, the Cleveland Clinic announced a strategic alliance with Theranos to "enhance clinical quality, improve turnaround times, reduce the cost of care and increase patient satisfaction" through the start-up's technology.
Theranos claims its proprietary Edison machine is able to perform a range of sophisticated tests at low cost with just a few drops of blood.
Earlier this month, The Wall Street Journal cited a former Theranos employee who said just 15 of the 240 tests offered by the company were conducted on Edison machines, with the rest performed on traditional lab equipment. The "company says it abides by all applicable federal lab regulations and hasn't exaggerated its achievements. It disputes that its device could do just 15 tests," according to the Journal article.
Cosgrove said the Cleveland Clinic does not yet have Theranos technology on-site, but it is looking forward to performing a peer review.
Theranos has attracted skepticism in part because founder Elizabeth Holmes decided to have the Food and Drug Administration review the quality of its results rather than the taking the traditional approach of independent peer review.
"That has been a slower process, and this is one of the reasons why I think the scientific community has been questioning what is the capability," of the machines, he said.